These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 156793)

  • 1. L-Chlorozotocin.
    Johnston TP; McCaleb GS; Anderson T; Murinson DS
    J Med Chem; 1979 May; 22(5):597-9. PubMed ID: 156793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
    Fox PA; Panasci LC; Schein PS
    Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
    Anderson T; McMenamin MG; Schein PS
    Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
    Nagourney RA; Fox P; Schein PS
    Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
    Schein PS; Panasci L; Woolley PV; Anderson T
    Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas.
    Ahlgren JD; Green DC; Tew KD; Schein PS
    Cancer Res; 1982 Jul; 42(7):2605-8. PubMed ID: 6211225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
    Macdonald JS; Hoth D; Schein PS
    Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells.
    Dean SW; Tew KD; Clark AE; Schein PS
    Br J Cancer; 1985 Sep; 52(3):377-82. PubMed ID: 2931097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro.
    Lazarus P; Germina JS; Dufour M; Palmer G; Wallace D; Panasci LC
    Cancer Chemother Pharmacol; 1983; 11(3):159-61. PubMed ID: 6227421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin.
    Johnston TP; McCaleb GS; Montgomery JA
    J Med Chem; 1975 Jan; 18(1):104-6. PubMed ID: 122802
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular and molecular mechanisms of the bone marrow sparing effects of the glucose chloroethylnitrosourea chlorozotocin.
    Byrne P; Tew K; Jemionek J; MacVittie T; Erickson L; Schein P
    Blood; 1984 Apr; 63(4):759-67. PubMed ID: 6322885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
    Aoshima M; Sakurai Y
    Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Heal JM; Fox PA; Doukas D; Schein PS
    Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies of methylnitrosourea antitumor agents with reduced murine bone marrow toxicity.
    Panasci LC; Fox PA; Schein PS
    Cancer Res; 1977 Sep; 37(9):3321-8. PubMed ID: 141978
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sites.
    Green D; Tew KD; Hisamatsu T; Schein PS
    Biochem Pharmacol; 1982 May; 31(9):1671-9. PubMed ID: 7104031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic activity of MCNU: a new antitumor agent.
    Sekido S; Ninomiya K; Iwasaki M
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N,N'-bis(2-chloroethyl)-N-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-2-deoxy-D-glucopyranose upon the proliferation, DNA synthesis, and viability of cultured sensitive and resistant L1210 cells.
    Wheeler GP; Alexander JA; Adamson DJ
    Cancer Res; 1980 Oct; 40(10):3723-7. PubMed ID: 6449283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of three new nitrosourea analogs (CNCC, RFCNU and chlorozotocin) on in vivo destruction of L 1210 leukemia cells and on the immune response.
    Andrade Mena CE; Orbach-Arbouys S; Cosmatopoulos K; Mathé G
    Chemotherapy; 1986; 32(2):131-7. PubMed ID: 2938892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.